VIRIDIAN PHARMA LTD

BN13 3QZ (South East)

Start Date

End Date Funded Value Relevance

CSV

25 50 100

£66,701

Feb 14 - Nov 14

Development of a novel membrane coating technology for the formulation of orally disintegrating tablets to deliver flucloxacillin

Innovate UK award to VIRIDIAN PHARMA LTD and Chris Martin

{{facetGroup.name}}

{{getFilterText(facet,showCount)}}